For many, the transition from the professional intensity of the workday to the relaxation of the evening follows a well-trodden path: a glass of wine, a craft beer, or perhaps a soothing herbal tea. Yet, a burgeoning corner of the beverage industry is betting that the future of unwinding lies in the ancient botanical traditions of Southeast Asia and the South Pacific.
Kratom (Mitragyna speciosa) and kava (Piper methysticum) are moving from the fringes of "smoke shop" culture into the mainstream retail spotlight. Leading this charge is Mitra9, a company that has successfully transitioned these potent botanicals into the ready-to-drink (RTD) category. By focusing on extraction technology, consumer education, and radical transparency, the brand is attempting to redefine how society views functional, non-alcoholic social tonics.
The Rise of the "Third Living Room"
The cultural momentum behind kratom and kava is rooted in a shift toward sobriety and "sober-curious" lifestyles. For Dallas Vasquez, founder and CEO of Mitra9, the initial encounter with this space was accidental. In 2019, while searching for a way to socialize without the presence of alcohol, he was introduced to a local kava bar.
"I loved the effect. I loved that it was a gathering place where there was no alcohol," Vasquez recalls. "I stopped drinking alcohol around that same time period, right before 2020, and was looking for an alternative."
This observation coincided with a broader sociological trend. Even before the pandemic, but certainly accelerating in its wake, kava bars began to function as "third living rooms"—communal spaces that prioritize connection over intoxication. However, these spaces were geographically limited to specific regions, such as Florida, leaving a massive untapped market of consumers who desired the experience without the necessity of visiting a specialized establishment.
From Smoke Shops to Store Shelves: A Chronology of Disruption
The path to commercializing these botanicals was far from straightforward. Historically, kratom products were relegated to the "two-ounce shot" format found in tobacco shops and convenience stores. These products were often criticized for their unpalatable taste and inconsistent dosing.
2019–2020: Market Discovery
Vasquez identified a clear disconnect: while there was a robust market for the ingredients, the delivery mechanisms were archaic. Consumers were forced to choke down concentrated, often bitter shots to achieve the desired effect.
2021: The Innovation Pivot
Recognizing that the "shot" model was a barrier to mass-market adoption, Vasquez and his team spent a year developing extraction technology. The goal was to isolate the specific alkaloids—mitragynine from the kratom leaf—while removing the bitter, earthy flavor profile. By late 2021, Mitra9 began canning its first 12-ounce ready-to-drink beverages.
2022–Present: Mainstream Expansion
The brand moved rapidly from niche retailers into gas stations, convenience stores, and health-focused outlets. This evolution required a fundamental shift in marketing strategy: the product could no longer be sold as a curiosity; it had to be sold as a functional lifestyle beverage that tastes "good, period"—not just "good for a supplement."
The Complexity of Botanical Marketing
Operating in the botanical beverage space presents unique challenges that traditional CPG (consumer packaged goods) companies do not face. These include regulatory hurdles, advertising restrictions, and a high degree of consumer skepticism.
Navigating the Advertising Landscape
Mitra9 utilizes a hybrid approach to marketing, balancing direct buys with programmatic advertising. However, the programmatic environment is notoriously restrictive for products that touch on mood-altering substances.
"Our products cannot be sold on certain platforms," Vasquez notes. "So we really have to make sure we’re delivering the right message, and that everything is in compliance with whatever outlet we’re trying to advertise through."
This requires a delicate balance: the company must convey the efficacy of the product without making prohibited medical claims, all while adhering to the shifting content policies of major digital ad exchanges.
Addressing Consumer Skepticism
The "elephant in the room" remains the nature of kratom itself. Because certain alkaloids in the plant interact with opioid receptors, the industry is under constant regulatory and public scrutiny. Mitra9 addresses this through what Vasquez calls "radical transparency."
In an emerging category, education is the marketing. If a consumer doesn’t understand the ingredient, they won’t purchase it. Mitra9 has integrated "batch testing" into its DNA, providing consumers with access to certificates of analysis (COAs) on their website. These documents track the raw material from the initial extraction through to the finished product, ensuring safety and consistency—a practice borrowed from the more established dietary supplement industry.
Scientific and Regulatory Implications
The broader implications for the kratom and kava industry are significant. As these products move into the hands of the general public, the standards for quality control are being forced upward.
Understanding the Mechanism
The efficacy of kratom is highly dosage-dependent. At lower concentrations, it is widely reported to act as a stimulant, while higher concentrations are associated with sedation. Mitra9 aims to provide a consistent, predictable experience, distancing itself from the "hit or miss" nature of raw botanical powders.
The "Functional" Competitive Landscape
Vasquez is careful to differentiate Mitra9 from the burgeoning THC-infused beverage market. "We’re not really competing with alcohol; I think the THC space has done that," he explains. "We’re trying to compete in our own space as a functional beverage."
By positioning the drink as a ritualistic experience—comparable to a morning coffee or a post-work tea—the company is carving out a niche that emphasizes mood enhancement rather than impairment. This is a critical distinction that allows the brand to avoid the "recreational substance" stigma that often plagues the cannabis beverage industry.
Official Stance: The Education-First Strategy
When asked how to build trust in a skeptical market, Vasquez is firm: "In any emerging category, transparency does more work than hype."
This philosophy manifests in several operational pillars:
- Consistent Dosing: By using refined extracts, the company ensures that a 12-ounce can provides a predictable experience, preventing the "over-consumption" risks associated with raw plant matter.
- Open-Book Policy: By making safety testing public, the brand attempts to demystify the botanical, turning a "scary" unknown into a verifiable, regulated beverage.
- Social Rituals: The marketing focus is entirely on the "why"—meeting people at the intersection of social anxiety and the need for a ritualistic, calming transition at the end of the day.
The Future of the "Functional" Beverage Market
The success of Mitra9 serves as a case study for the maturation of the alternative beverage industry. As consumers continue to move away from alcohol, the demand for sophisticated, functional alternatives will only grow. However, the path to market share is gated by the need for rigorous science and uncompromising consumer education.
For Mitra9, the journey has been one of constant adaptation. They have had to transition from the "smoke shop" aesthetic to a more polished, lifestyle-oriented branding that fits alongside energy drinks and wellness tonics in mainstream retail.
As the industry continues to evolve, the distinction between "supplement" and "beverage" will likely blur further. If companies like Mitra9 can maintain their commitment to safety and transparency, they may well prove that the future of the evening wind-down isn’t found in a bottle of wine, but in the carefully extracted leaves of the Mitragyna speciosa tree.
Ultimately, the company’s trajectory suggests that the "third living room" is no longer just a physical location—it is a mindset, one that favors clarity, connection, and the pursuit of mood-enhancing alternatives that respect the consumer’s need for both safety and experience. As the regulatory landscape matures, the brands that win will be those that treat their consumers as partners in a process of discovery, proving that you can indeed be an "open book" while building a successful, modern business.
